Woodline Partners’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Hold
50,120
0.01% 826
2025
Q4
$1.59M Sell
50,120
-45,000
-47% -$1.35M 0.01% 800
2025
Q3
$2.24M Hold
95,120
0.01% 716
2025
Q2
$1.08M Hold
95,120
0.01% 797
2025
Q1
$633K Buy
95,120
+217
+0.2% +$2.02K ﹤0.01% 810
2024
Q4
$1.05M Buy
94,903
+521
+0.6% +$6.4K 0.01% 751
2024
Q3
$1.16M Sell
94,382
-5,800
-6% -$82.2K 0.01% 501
2024
Q2
$1.35M Sell
100,182
-6,722
-6% -$90.8K 0.01% 444
2024
Q1
$1.44M Buy
106,904
+50,000
+88% +$303K 0.01% 445
2023
Q4
$299K Hold
56,904
﹤0.01% 445
2023
Q3
$224K Sell
56,904
-40,120
-41% -$264K ﹤0.01% 549
2023
Q2
$1.03M Hold
97,024
0.01% 484
2023
Q1
$808K Buy
+97,024
New +$875K 0.01% 489

Other funds holding STOK